Publicaciones en las que colabora con Jeffrey V. Lazarus (11)

2024

  1. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, Núm. 29

  2. Determinants of Intention to Use HIV Pre-exposure Prophylaxis and Condom Use Among a Sample of Cisgender Female Sex Workers Working Mostly Outdoors in Madrid, Spain

    Archives of Sexual Behavior, Vol. 53, Núm. 7, pp. 2817-2831

  3. HIV-infected Latin American asylum seekers in Madrid, Spain, 2022: A prospective cohort study from a major gateway in Europe

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, Núm. 29

  4. Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

    JAMA network open, Vol. 7, Núm. 10, pp. e2438657

2023

  1. Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

    Communications Medicine, Vol. 3, Núm. 1

2022

  1. A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

    Communications Medicine, Vol. 2, Núm. 1

  2. Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

    Liver International, Vol. 42, Núm. 2, pp. 309-319

  3. Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 34, Núm. 10, pp. 1297-1304

2021

  1. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain

    International Journal of Drug Policy, Vol. 96

  2. Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain

    Open Forum Infectious Diseases, Vol. 8, Núm. 7

  3. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA

    Clinical Gastroenterology and Hepatology, Vol. 19, Núm. 7, pp. 1451-1458.e4